Evidence map›Paper›PMID 36245624›Full record

ArticleJournal of thoracic disease2022

Mediastinal lymph node evaluation, especially at station 4L, in left upper lobe lung cancer.

Jun Hanaoka, Makoto Yoden, Keigo Okamoto, Ryosuke Kaku, Yasuhiko Ohshio

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06496360 (Prediction Model of Mediastinal Group IV Lymph Node Metastasis in Non-small Cell Lung Cancer Based on CT Radiomics), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06496360 unknown statusnot on this mapstarted 2024, after this paper: background citation

Prediction Model of Mediastinal Group IV Lymph Node Metastasis in Non-small Cell Lung Cancer Based on CT Radiomics

TypeobservationalSponsorQilu Hospital of Shandong UniversityRan2024 to 2025Enrolled150ConditionsNon-small Cell Lung CancerArmsArtificial Intelligence
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jun HanaokaDivision of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan.
Makoto YodenDivision of General Thoracic Surgery, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Keigo OkamotoDivision of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan.
Ryosuke KakuDivision of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan.
Yasuhiko OhshioDivision of General Thoracic Surgery, Department of Surgery, Shiga University of Medical Science, Otsu, Japan.
Shiga University of Medical Science · JPKyoto Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mediastinal lymph node (LN) dissection during lung resection is essential for accurate staging. Station 4L dissection is anatomically difficult. Therefore, care should be taken to avoid complications. We investigated the importance of mediastinal LN dissection in left upper lobe lung cancer and evaluated intraoperative videos to identify relevant steps during dissection. Methods: We retrospectively reviewed 151 consecutive patients with left upper lobe lung cancer. Finally, 139 patients were enrolled to examine the survival effects of clinical factors of metastatic LN stations. The association between risk factors or surgical procedures and recurrent laryngeal nerve palsy was analyzed. Results: LN dissection of the left upper lobe revealed station 4L LN metastasis in nine patients, three of whom were node-negative on mediastinoscopy. Station 4L LN status was confirmed intraoperatively in 12 of 33 patients. Twenty patients had recurrent laryngeal nerve palsy, four of whom were complicated with aspiration pneumonia. Station 4L LN dissection was an independent risk factor for recurrent laryngeal nerve palsy (P=0.03). The use of an energy device near the recurrent laryngeal nerve was a significant risk factor for recurrent laryngeal nerve palsy. Incidentally, pathological N stage ≥2 was an independent prognostic factor for disease-free survival (DFS) (P=0.005) herein. Conclusions: In patients with left upper lobe lung cancer, pathological N2 disease is an important predictor of recurrence. Therefore, accurate mediastinal LN dissection, including at station 4L, should be performed. We propose to standardize the dissection procedure at each institution to avoid complications, such as recurrent laryngeal nerve palsy.

Indexed as

Lung cancerlymph node dissectionlymph node (LN)recurrent laryngeal nerve palsyvideo-assisted thoracoscopic surgery

Identifiers

PMID36245624
PMCPMC9562556
OpenAlexW4294693695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.